Key Facts About McKesson – A Comprehensive Compilation

By Kim Brooks • Wednesday, February 07 15:39 • Permanent Link

With gains of 2.1%, McKesson was one of the winners on Wall Street today. Its shares are now trading at $517.62 and have logged a 1.0% daily outperformance of the S&P 500. Don't join the feeding frenzy before checking some basic facts about this stock:

McKesson has moved 38.2% over the last year, and the S&P 500 logged a change of 20.3%
MCK has an average analyst rating of buy and is -0.04% away from its mean target price of $517.81 per share
Its trailing earnings per share (EPS) is $25.29
McKesson has a trailing 12 month Price to Earnings (P/E) ratio of 20.5 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $30.82 and its forward P/E ratio is 16.8
McKesson is part of the Health Care sector, which has an average P/E ratio of 30.21 and an average P/B of 4.08
MCK has reported YOY quarterly earnings growth of -23.3% and gross profit margins of 0.0%
The company has a free cash flow of $4.88 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.